Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

US Patent 9850264 · Granted Dec 26, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidaz2022
Phenyl urea derivatives as N-formyl peptide receptor modulators2022
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof2021
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof2021
Phenyl urea derivatives as n-formyl peptide receptor modulators2021
Sulfur derivatives as chemokine receptor modulators2021
Sulfur derivatives as chemokine receptor modulators2021
Sulfur derivatives as chemokine receptor modulators2021
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor l2021
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor l2021
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor l2021
Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory di2021